← Leaderboards
Shrabasti Roychoudhury
University Of Nebraska Medical Center
$453,050
Attributed
$453,050
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $104.4K · FY2017–22$200K$150K$100K$50K$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$453,050 · 2
By mechanism
K00$391,728 · 1
F99$61,322 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Nebraska Medical Center
Same institution · by research overlap
- Jonathan L Vennerstrom$7,293,146
- Paul D Fey$8,043,719
- Amarnath Natarajan$8,497,174
- Ira J. Fox$16,510,315
- Corey R. Hopkins$7,733,878
Others in their field
Other Emerging Leaders on “Combinatorial”
- Bryan Roth · Univ Of North Carolina Chapel Hill$12,367,722
- Paul John Norman · University Of Colorado Denver$8,178,212
- Ansuman Satpathy · Stanford University$7,721,054
- Robert Nicol · Broad Institute, Inc.$7,498,771
- Tina Garyantes · Linnaeus Therapeutics, Llc$6,999,960
- Liangcai Gu · University Of Washington$6,742,121
Research focus
CombinatorialChromatinAcetylationCisplatinAspergillus Nuclease S1BiochemicalBaseAngiogenesisBase Excision RepairsChip-SeqBindingCancer ImmunotherapyCancer TherapyCancer TypeCarcinogensCareerCell ProliferationCellsCell SurvivalCancer BiologyCancer CellChemotherapeutic AgentCancer Cell LineCoupled
Grant awards (6)
Cancer Therapeutic Resistance: Implication of AcAPE1 Mediated DNA Repair and T-Cell Based Immunotherapy$104,370
K00 · FY2022 · CA · contact PI
Cancer Therapeutic Resistance: Implication of AcAPE1 Mediated DNA Repair and T-Cell Based Immunotherapy$99,808
K00 · FY2021 · CA · contact PI
Cancer Therapeutic Resistance: Implication of AcAPE1 Mediated DNA Repair and T-Cell Based Immunotherapy$95,246
K00 · FY2020 · CA · contact PI
Cancer Therapeutic Resistance: Implication of AcAPE1 Mediated DNA Repair and T-Cell Based Immunotherapy$92,304
K00 · FY2019 · CA · contact PI
Cancer Therapeutic Resistance: Implication of AcAPE1 Mediated DNA Repair and T-Cell Based Immunotherapy$30,151
F99 · FY2018 · CA · contact PI
Cancer Therapeutic Resistance: Implication of AcAPE1 Mediated DNA Repair and T-Cell Based Immunotherapy$31,171
F99 · FY2017 · CA · contact PI